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In his article, Rehm sets out the case for combining cause-specific studies when seeking to estimate 
the risks of mortality associated with different levels of alcohol consumption, rather than using 
studies where all-cause mortality is the endpoint (1). His primary argument is that individuals 
included in all-cause mortality studies are not demographically representative of the wider 
population and the proportion of deaths which are from alcohol-related health conditions will 
therefore also be somewhat unrepresentative. It is hard to disagree with this point and it can be 
extended to limit the validity of all-cause mortality studies to populations other than those from 
which the underlying data are drawn. More broadly, all-cause mortality studies embed not only the 
demographic characteristics of the included population, but also their patterns of alcohol 
consumption, such as levels of heavy episodic drinking, which are known to be related to mortality 
risks (2).  Epidemiological studies do not usually capture drinking patterns and systematic differences 
in such patterns between study and general populations may further bias the results of all-cause 
studies. 
ZĞŚŵ ?ƐƌĞĐŽŵŵĞŶĚĂƚŝŽŶŝƐƚŚĂƚǁĞƐŚŽƵůĚĐŽŵďŝŶĞĐŽŶĚŝƚŝŽŶ-specific estimates of alcohol-related 
risks. This approach addresses some of the limitations of all-cause studies and is used in several 
influential public health tools, including the Global Burden of Disease (GBD) study (3) and our own 
Sheffield Alcohol Policy Model (SAPM) (4). In particular, weighting the influence of each condition by 
its prevalence in the population of interest (e.g. a country), tailors the resulting risk curve to the real 
health risks faced by drinkers in a specific time and place.  
Determining the weights to assign to each health condition is far from a trivial exercise. The GBD 
study referred to by Rehm used the aggregate prevalence of mortality from each health condition 
across the globe (3). There are two problems with this approach: the first is that, as Rehm notes, the 
 ‘ĐŽƌƌĞĐƚ ?ǁĞŝŐŚƚƐǁŽƵůĚďĞďĂƐĞĚŽŶŵŽƌƚĂůŝƚǇ rates in non-drinkers only. The GBD approach thus 
gives unduly high weight to health conditions for which alcohol is responsible for a substantial 
proportion of deaths, such as liver disease, while ƚŚĞ ‘ĐŽƌƌĞĐƚ ?ǁĞŝŐŚƚƐĐĂŶŽŶůǇďĞĚĞƚĞƌŵŝŶĞĚ
through complex modelling processes. The second is that the resulting risk curve represents the 
average risk across all included populations modelled (e.g. countries) rather than the actual risks 
faced by an individual in a particular population. A further limitation is that conditions that are 
wholly-attributable to alcohol, such as alcohol poisoning, are excluded from the cause-specific 
approach, as non-drinkers have zero risk for such conditions by definition, and therefore their 
relative risk is undefined. We resolve this issue in SAPM through the use of additional absolute risk 
curves for wholly-attributable conditions. More complex approaches are also required in order for 
injuries and other health conditions associated with intoxication, rather than typical consumption, to 
be included in these calculations. 
Finally, as Rehm notes, cause-specific mortality studies are also subject to many of the same biases 
as all-cause studies. He suggests overcoming this by including cause-specific studies undertaken in 
populations who are underrepresented in typical studies, such as the homeless or those in 
institutional accommodation. It is not clear, however, if these studies exist in practice, and precisely 
how to combine multiple studies in order to address issues of underrepresentation. Whilst Rehm 
presents a compelling case against all-cause studies, caution is required when moving from a simple 
approach with well-understood and recognised limitations to a much more data intensive approach 
with less clear and, due to the complexity of the method, often less transparent inherent 
assumptions and limitations. The more complex approach may be preferable in many situations due 
to its greater specificity to the population of interest, but in situations where data are limited, or 
high-quality all-cause studies from similar populations are available, the simpler approach may still 
be appropriate. 
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